L-methionine in patients with neurogenic bladder disorders: Executive summary of final report A04-02, Version 1.0

Authors
Category Primary study
BookIn: Institute for Quality and Efficiency in Health Care: Executive Summaries. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG)
Year 2005
The aim of this research was to assess the benefit of treatment with L-methionine in patients with neurogenic bladder disorders versus another drug- or non-drug intervention or versus placebo. The focus of the assessment was on patient-relevant outcomes. The interventions had to be used with the aim of preventing or treating urinary tract infections (UTIs) or urinary stones (phosphate stones).
Epistemonikos ID: ef37e94e4f6be45f70ff2c4574aeed8aef3b4b0e
First added on: Mar 18, 2020